Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

12.41
BATS BZX Real-Time Price
As of 3:55pm ET
 +0.64 / +5.44%
Today’s Change
8.38
Today|||52-Week Range
20.00
-21.65%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close11.77
Today’s open11.95
Day’s range11.76 - 12.36
Volume304,823
Average volume (3 months)629,234
Market cap$618.5M
Dividend yield--
Data as of 3:40pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+13.26%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book6.60

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.13+4.88%
CHMAChiasma Inc+2.09+8.03%
PETXAratana Therapeutics...+0.98+5.59%
SGNTSagent Pharmaceutica...+0.55+2.85%
Data as of 3:55pm ET, 09/02/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

Partner Offers